Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
JCO Precision Oncology|October 24, 2024
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital HistopathologyJonathan David Tward, Huei-Chung Huang, Andre Esteva, et al.JAMA Oncology|October 20, 2022
Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical TrialJoshua D Palmer, Brett G Klamer, Karla V Ballman, et al.International Journal of Radiation Oncology, Biology, Physics|December 17, 2021
Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126William A Hall, Snehal Deshmukh, Deborah W Bruner, et al.International Journal of Radiation Oncology, Biology, Physics|September 4, 2021
Adding Short-Term Androgen Deprivation Therapy to Radiation Therapy in Men With Localized Prostate Cancer: Long-Term Update of the NRG/RTOG 9408 Randomized Clinical TrialChristopher U Jones, Stephanie L Pugh, Howard M Sandler, et al.Cancer|December 29, 2022
Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126Andrew M McDonald, Lyudmila DeMora, Eddy S Yang, et al.International Journal of Radiation Oncology, Biology, Physics|June 19, 2018
Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate CancerHimanshu R Lukka, Stephanie L Pugh, Deborah W Bruner, et al.International Journal of Radiation Oncology, Biology, Physics|April 7, 2020
Phase 2 Study of a Temozolomide-Based Chemoradiation Therapy Regimen for High-Risk, Low-Grade Gliomas: Long-Term Results of Radiation Therapy Oncology Group 0424Barbara J Fisher, Stephanie L Pugh, David R Macdonald, et al.JCO Precision Oncology|September 30, 2021
Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II GliomaJessica L Fleming, Stephanie L Pugh, Barbara J Fisher, et al.Neuro-Oncology|December 6, 2022
Association of circulating markers with cognitive decline after radiation therapy for brain metastasisKristin Huntoon, S Keith Anderson, Karla V Ballman, et al.The New England Journal of Medicine|February 2, 2017
Radiation with or without Antiandrogen Therapy in Recurrent Prostate CancerWilliam U Shipley, Wendy Seiferheld, Himanshu R Lukka, et al.Pageof 9